Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ONC
Stock Latest News
Company Announcements
BeOne Medicines Halts Early KRAS Trial, Resetting Expectations in a Crowded Oncology Race
1d ago
ONC
Premium
Company Announcements
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
1d ago
ONC
ZYME
Premium
The Fly
BeOne Medicines price target raised to $436 from $425 at RBC Capital
2d ago
ONC
Premium
Company Announcements
New Combo Trial in Esophageal Cancer: What LBL-007’s Phase 2 Update Means for ONC Investors
7d ago
ONC
Premium
The Fly
BeOne Medicines’ combination shows improved survival in adenocarcinoma
8d ago
ONC
Premium
Company Announcements
BeOne Medicines Advances First-in-Human Solid Tumor Trial With BG-C0979
8d ago
ONC
Premium
Company Announcements
BeOne Medicines Pits New Breast Cancer Drug Against CDK4/6 Leaders in Phase 3 Test
13d ago
ONC
Premium
Company Announcements
BeOne Medicines Halts Early Lung Cancer Trial, Resetting Expectations for EGFR Pipeline
13d ago
ONC
Premium
Company Announcements
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
20d ago
8K
ONC
Premium
The Fly
BeOne Medicines price target raised to $367 from $364 at Leerink
20d ago
ONC
Premium
The Fly
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
22d ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
28d ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $409 from $405 at Barclays
28d ago
ONC
Premium
The Fly
BeOne Medicines price target raised to $420 from $410 at Guggenheim
29d ago
ONC
Premium
The Fly
BeOne Medicines reports Q1 adjusted EPS $3.24 vs. $1.22 last year
29d ago
ONC
Premium
The Fly
BeOne Medicines raises FY26 revenue view to $6.3B-$6.5B from $6.2B-$6.4B
29d ago
ONC
Premium
The Fly
AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
1M ago
AMD
BDX
Premium
The Fly
BeOne Medicines initiated with an Overweight at Wells Fargo
1M ago
ONC
Premium
The Fly
BeOne Medicines: FDA grants Priority Review to sBLA for tevimbra/ziihera combo
1M ago
ONC
Premium
The Fly
BeOne Medicines price target lowered to $411 from $412 at Truist
2M ago
ONC
Premium
Ratings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
2M ago
ONC
Premium
The Fly
BeOne Medicines initiated with an Outperform at Wolfe Research
2M ago
ONC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
